38.60000 EUR
4
9.39%
Last update Dec 17, 7:31 PM CET
Main market
Day range
38.60000
42.40000
Previous close
42.60000
Open
41.60000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
38.60
4
9.39%

Statistics

Valuation metrics
Market cap
0
Enterprise value
49.71M
Trailing P/E (ttm)
-4.37
Forward P/E
PEG ratio
0.14
Price/Sales (ttm)
0
Price/Book (mrq)
8.46
Enterprise Value/Revenue
0.59
Enterprise Value/EBITDA
-0.52
Overview
Shares outstanding
19.65M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
2
Average volume (90 days)
1
Price summary
52-Week low
6.23
52-Week high
56.50
52-Week change
63.19 1,015.1%
Beta
50-Day moving average
49.46
200-Day moving average
26.65
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
68.82%
Operating margin
-92.54%
Operational effectiveness
Return on assets
-39.15%
Return on equity
-195.86%
Income statement
Revenue (ttm)
83.91M
Revenue per share (ttm)
7.18
Quarterly revenue growth (yoy)
5.50%
Gross profit (ttm)
57.75M
EBITDA
0
Net income to common (ttm)
-101.41M
Diluted EPS (ttm)
-8.70
Quarterly earnings growth (yoy)
-51.81%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
78.36M
Total Debt/Equity (mrq)
1.08
Current ratio (mrq)
424.11%
Book value per share (mrq)
4.49
Cash flow
Cash flow statement
-124.54M
Levered free cash flow (LFCF)
-101.41M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 19 minutes

14:40
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).